Oxatomide: Difference between revisions
No edit summary |
No edit summary |
||
Line 44: | Line 44: | ||
| StdInChIKey = BAINIUMDFURPJM-UHFFFAOYSA-N | | StdInChIKey = BAINIUMDFURPJM-UHFFFAOYSA-N | ||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}} | |||
==Overview== | |||
'''Oxatomide''' (R35443) is a [[first-generation antihistamine]] of the [[phenylpiperazine]] class.<ref name="pmid6138301">{{cite journal | author = Ohmori K, Ishii H, Nito M, Shuto K, Nakamizo N | title = [Pharmacological studies on oxatomide (KW-4354). (7) Antagonistic effects on chemical mediators] | language = Japanese | journal = Nippon Yakurigaku Zasshi. Folia Pharmacologica Japonica | volume = 81 | issue = 5 | pages = 399–409 |date=May 1983 | pmid = 6138301 | doi = 10.1254/fpj.81.399| url = }}</ref> It was discovered at [[Janssen Pharmaceutica]] in 1975. Oxatomide lacks any [[anticholinergic]] effects.<ref name="pmid6138301">{{cite journal | author = Ohmori K, Ishii H, Nito M, Shuto K, Nakamizo N | title = [Pharmacological studies on oxatomide (KW-4354). (7) Antagonistic effects on chemical mediators] | language = Japanese | journal = Nippon Yakurigaku Zasshi. Folia Pharmacologica Japonica | volume = 81 | issue = 5 | pages = 399–409 |date=May 1983 | pmid = 6138301 | doi = 10.1254/fpj.81.399| url = }}</ref> In addition to its [[H1 receptor|H<sub>1</sub> receptor]] [[receptor_antagonist|antagonism]], it also possesses [[antiserotonergic]] actions.<ref name="pmid6138301">{{cite journal | author = Ohmori K, Ishii H, Nito M, Shuto K, Nakamizo N | title = [Pharmacological studies on oxatomide (KW-4354). (7) Antagonistic effects on chemical mediators] | language = Japanese | journal = Nippon Yakurigaku Zasshi. Folia Pharmacologica Japonica | volume = 81 | issue = 5 | pages = 399–409 |date=May 1983 | pmid = 6138301 | doi = 10.1254/fpj.81.399| url = }}</ref> | '''Oxatomide''' (R35443) is a [[first-generation antihistamine]] of the [[phenylpiperazine]] class.<ref name="pmid6138301">{{cite journal | author = Ohmori K, Ishii H, Nito M, Shuto K, Nakamizo N | title = [Pharmacological studies on oxatomide (KW-4354). (7) Antagonistic effects on chemical mediators] | language = Japanese | journal = Nippon Yakurigaku Zasshi. Folia Pharmacologica Japonica | volume = 81 | issue = 5 | pages = 399–409 |date=May 1983 | pmid = 6138301 | doi = 10.1254/fpj.81.399| url = }}</ref> It was discovered at [[Janssen Pharmaceutica]] in 1975. Oxatomide lacks any [[anticholinergic]] effects.<ref name="pmid6138301">{{cite journal | author = Ohmori K, Ishii H, Nito M, Shuto K, Nakamizo N | title = [Pharmacological studies on oxatomide (KW-4354). (7) Antagonistic effects on chemical mediators] | language = Japanese | journal = Nippon Yakurigaku Zasshi. Folia Pharmacologica Japonica | volume = 81 | issue = 5 | pages = 399–409 |date=May 1983 | pmid = 6138301 | doi = 10.1254/fpj.81.399| url = }}</ref> In addition to its [[H1 receptor|H<sub>1</sub> receptor]] [[receptor_antagonist|antagonism]], it also possesses [[antiserotonergic]] actions.<ref name="pmid6138301">{{cite journal | author = Ohmori K, Ishii H, Nito M, Shuto K, Nakamizo N | title = [Pharmacological studies on oxatomide (KW-4354). (7) Antagonistic effects on chemical mediators] | language = Japanese | journal = Nippon Yakurigaku Zasshi. Folia Pharmacologica Japonica | volume = 81 | issue = 5 | pages = 399–409 |date=May 1983 | pmid = 6138301 | doi = 10.1254/fpj.81.399| url = }}</ref> | ||
Line 51: | Line 56: | ||
==References== | ==References== | ||
{{Reflist}} | {{Reflist|2}} | ||
{{Antihistamines}} | {{Antihistamines}} | ||
[[Category:H1 receptor antagonists]] | [[Category:H1 receptor antagonists]] | ||
Line 63: | Line 66: | ||
[[Category:Ureas]] | [[Category:Ureas]] | ||
[[Category:Lactams]] | [[Category:Lactams]] | ||
[[Category: | [[Category:Drug]] | ||
Latest revision as of 15:28, 10 April 2015
Clinical data | |
---|---|
Trade names | Tinset, Cedlips, Atoxan |
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C27H30N4O |
Molar mass | 426.553 g/mol |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
WikiDoc Resources for Oxatomide |
Articles |
---|
Most recent articles on Oxatomide |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Oxatomide at Clinical Trials.gov Clinical Trials on Oxatomide at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Oxatomide
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Oxatomide Discussion groups on Oxatomide Directions to Hospitals Treating Oxatomide Risk calculators and risk factors for Oxatomide
|
Healthcare Provider Resources |
Causes & Risk Factors for Oxatomide |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Oxatomide (R35443) is a first-generation antihistamine of the phenylpiperazine class.[1] It was discovered at Janssen Pharmaceutica in 1975. Oxatomide lacks any anticholinergic effects.[1] In addition to its H1 receptor antagonism, it also possesses antiserotonergic actions.[1]
See also
References
- Pages with script errors
- CS1 maint: Multiple names: authors list
- CS1 maint: Unrecognized language
- Template:drugs.com link with non-standard subpage
- Drugs with non-standard legal status
- Articles with changed CASNo identifier
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Chemical pages without DrugBank identifier
- Drugboxes which contain changes to verified fields
- H1 receptor antagonists
- Piperazines
- Benzimidazoles
- Ureas
- Lactams
- Drug